Trials Offered by a Specific Doctor

DEPARTMENT OF HEMATOLOGY AND ONCOLOGY
Investigator
Dawn Hershman, MD
Phone
1 212 305 1945
Email
dlh23@cumc.columbia.edu
(Biography not available)

Clinical Studies Managed By Dr. Hershman:
More InfoTitleSponsorIRB Number
DetailsUsing New Imaging Technique in Women with Breast Cancer to predict response to Neoadjuvant ChemotherapyInvestigator initiated studyAAAI0480
DetailsStudy Evaluating Everolimus with Endocrine Therapy in Breast Cancer PatientsSouthwest Oncology GroupAAAL3751
DetailsA Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)Eastern Cooperative Oncology GroupAAAM2902
Details[CLOSED] Prospective Study of Chemotherapy-Induced Peripheral NeuropathyThompson Family FoundationAAAP4050
DetailsSemi-Structured Interviews with Patients about Chemotherapy-Induced Peripheral Neuropathy (CIPN)Columbia University Medical CenterAAAQ7714
DetailsTrACER: Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) for Patients Receiving ChemotherapySouthwest Oncology GroupAAAR0311
DetailsBWEL: Breast Cancer Weight Loss TrialNCI AllianceAAAR1073
DetailsThe ABC Trial: Study of Aspirin as Adjuvant Therapy for HER2 Negative Breast CancerNational Cancer InstituteAAAR7518
DetailsThe CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL (in Breast Cancer Patients)CUMCAAAR9515